2021 Biotech Outlook: Looking Back to Look Ahead

2020 was a rollercoaster year for the biopharma industry. It was also the year the entire industry changed; from a global response to a worldwide pandemic and an unprecedented effort around vaccine development, consideration of a new drug development model, and the emergence of new opportunities that will continue to propel the industry forward. Podcast … Continue reading 2021 Biotech Outlook: Looking Back to Look Ahead →